ESC 365 - Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

ESC Premium Access

Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Session: Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Topic: Thrombosis and platelets

Speaker: Professor R. Mehran (New York, US) Professor S. James (Uppsala, SE)

Sponsored by AstraZeneca

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speakers

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

58 presentations

16 followers

Professor Stefan James

Uppsala University, Uppsala (Sweden)

51 presentations

5 followers

3 more presentations in this session

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Early initiation of dual anti-platelet therapy following an acute coronary syndrome: a clinical case study.

Speaker: Professor S. James (Uppsala, SE)

Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Access the full session

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Speakers: Professor R. Mehran, Professor S. James, Professor R. Mehran, Professor S. James, Professor R. Mehran

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources